L. Stork

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

L. V. van't Veer, A. Glas, R. Bernards, 2016, The New England journal of medicine.

Genomic classifier (ColoPrint) to predict outcome and chemotherapy benefit in stage II and III colon cancer patients.

R. Salazar, I. Simon, J. Tabernero, 2013 .

Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

A. Glas, R. Bernards, C. Sotiriou, 2016 .

Title : 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

A. Glas, R. Bernards, C. Sotiriou, 2022 .

Validation of a genomic classifier (ColoPrint) for predicting outcome in the T3-MSS subgroup of stage II colon cancer patients.

V. Moreno, R. Salazar, P. Roepman, 2012 .